In this study, a Treat-to-Target (T2T) approach was considered for RA women preparing to conceive using an accepted combination of DMARDs, low-dose Prednisone, and Tumor Necrosis factor (TNF) inhibitors if needed. This evidence concerns the gene TNF and rheumatoid arthritis.